International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 3 , Pages 574-580, 1 July 2002

The role of p53 in radiation therapy outcomes for favorable-to-intermediate-risk prostate cancer

Presented at the 43rd Annual Meeting of the American Society for Therapeutic Radiology and Oncology, San Francisco, CA, November, 2001.

  • Mark A Ritter, M.D., Ph.D.

      Affiliations

    • Corresponding Author InformationReprint requests and correspondence to: Mark A. Ritter, M.D., Ph.D., Department of Human Oncology, K4/B100, 600 Highland Ave., Madison, WI 53792 USA. Tel: (608) 263-8509; Fax: (608) 263-9167
    • Department of Human Oncology, University of Wisconsin, Madison, WI USA
  • ,
  • Kennedy W Gilchrist, M.D.

      Affiliations

    • Department of Pathology, University of Wisconsin, Madison, WI USA
  • ,
  • Marta Voytovich, M.D.

      Affiliations

    • Department of Pathology, University of Wisconsin, Madison, WI USA
  • ,
  • Richard J Chappell, Ph.D.

      Affiliations

    • Department of Biostatistics, University of Wisconsin, Madison, WI, USA
  • ,
  • Bret M Verhoven

      Affiliations

    • Department of Human Oncology, University of Wisconsin, Madison, WI USA

Received 11 December 2001; accepted 28 January 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0360-3016(02)02781-5

International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 3 , Pages 574-580, 1 July 2002